Markus Leyck Dieken, M.D.
Medical Doctor with many years as clinician and almost 20 years in the pharmaceutical industry, now in digital health care. Amongst others, he was global head of the future program Teva 2021 for digital patient care. Before joining gematik, he was SVP Shionogi, responsible for the introduction of an antibiotic for bacterial resistance with the highest WHO priority, SVP at Intermune and VP at Novo Nordisk.
As CEO of gematik now leading a competent team to deliver the reliable and secure digital platform for Germany´s health care system. Potentially offering a connection of 70 mio people with almost 200.000 doctors, 20.000 pharmacies, 2.000 clinics an over 100 sick-funds and all important care specialists e.g. physiotherapists, home-care nurses and care-givers.